Literature DB >> 703786

Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria.

B F Felsher, M E Norris, J C Shih.   

Abstract

To test the diagnostic specificity of reduced red-cell uroporphyrinogen decarboxylase activity for porphyria cutanea tarda, we measured enzymic activity in 29 normal subjects and 65 patients with various forms of porphyria. Only patients with porphyria cutanea tarda had subnormal enzymic activity. Patients with acute intermittent porphyria, erythropoietic protoporphyria, variegate porphyria and hereditary coproporphyria had normal or slightly elevated activities. The enzymic activity in normal persons and patients with porphyria cutanea tarda did not differ according to sex. Reduction of iron stores did not alter the enzymic activity in porphyria cutanea tarda. We conclude that reduced red-cell uroporphyrinogen decarboxylase activity is a specific and intrinsic defect in porphyria cutanea tarda; measurement of this enzyme is a reliable diagnostic test for this disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 703786     DOI: 10.1056/NEJM197811162992002

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  7 in total

1.  The genetic basis of porphyria cutanea tarda.

Authors:  R Enriquez de Salamanca; A Olmos; M L Peña; L Berges; J Perpiñá
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  [Hereditary and non-hereditary form of chronic hepatic porphyria: different behaviour of uroporphyrinogen decarboxylase in liver and erythrocytes (author's transl)].

Authors:  M Doss; R von Tiepermann; D Look; H Henning; J Nikolowski; F Ryckmanns; O Braun-Falco
Journal:  Klin Wochenschr       Date:  1980-12-15

Review 3.  Environmental chemical exposures and disturbances of heme synthesis.

Authors:  W E Daniell; H L Stockbridge; R F Labbe; J S Woods; K E Anderson; D M Bissell; J R Bloomer; R D Ellefson; M R Moore; C A Pierach; W E Schreiber; A Tefferi; G M Franklin
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

4.  Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.

Authors:  H de Verneuil; C Beaumont; J C Deybach; Y Nordmann; Z Sfar; R Kastally
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

5.  [Influence of chloroquine on the hexachlorobenzene-induced porphyria. Investigations in the skin, liver, and urine (author's transl)].

Authors:  W Vizethum; K Bolsen; K Simon; K Weber; G Goerz
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

6.  Uroporphyrin I stimulation of collagen biosynthesis in human skin fibroblasts. A unique dark effect of porphyrin.

Authors:  G Varigos; J R Schiltz; D R Bickers
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

7.  Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication.

Authors:  F Sixel-Dietrich; M Doss
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.